Status:
COMPLETED
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
Lead Sponsor:
Hanyang University Seoul Hospital
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the efficacy of two prophylactic agent(aspirin 300mg/day and rivaroxaban 10mg/day) for venous thromboembolism after total knee arthroplasty.
Detailed Description
1. Thromboprophylactic regimens Aspirin®(acetylsalicylic acid, AA, Bayer) 300mg/day or Xarelto® (rivaroxaban, factor Xa-inhibitor, Bayer) 10mg/day will be randomly(according to the sequence of operati...
Eligibility Criteria
Inclusion
- all patients undergone primary total knee arthroplasty
Exclusion
- renal insufficiency, contrast allergy, simultaneous bilateral TKA, hemorrhagic disorder, sever liver disease
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT02271399
Start Date
October 1 2014
End Date
February 1 2016
Last Update
February 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Orthopaedic Surgery, Hanyang University, College of Medicine
Seoul, South Korea, 133-792